Research study Program year 2025 Source: CMS Open Payments

The Imagine Study: A Phase 3B Open Label, Single Arm Study to Assess T

Research payments

$108,463

12 payments

Through program year 2025, $108,463 in research payments was reported against The Imagine Study: A Phase 3B Open Label, Single Arm Study to Assess T, across 12 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$108,463	12

Breakdown

Who paid Research payments · program year 2025

GlaxoSmithKline, LLC. $108,463 12 payments

Who received the money Research payments · program year 2025

Hull And Hull Medical Specialists LLP Organisation paid for research $25,533 4 payments
Kumc Research Institute INC Organisation paid for research $19,601 2 payments
Temple University Organisation paid for research $19,085 1 payment
Conduct Clinical Trials Organisation paid for research $16,575 2 payments
Metroplex Pulmonary And Sleep Center PA Organisation paid for research $16,517 2 payments
Clinical Research Associates Of Central PA LLC Organisation paid for research $11,152 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

6 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.